Ovarian cancer

The treatment plan is not made by one person alone but in a round of surgery, oncology, radiology, pathology and radiotherapy. You may ask what was discussed there and which alternatives came up.

Before a big decision it is planned for in many clinics, and the records belong to you. It costs one to two weeks — acceptable in almost every course, and one asks about that if it is urgent.

It is today part of the treatment and not its opposite: it lessens the exhaustion, keeps muscle and bone and improves how the treatment is tolerated. Begin with guidance, less on bad days, but not nothing at all.

Unintended weight loss worsens how any treatment is tolerated. Restrictive diets do more harm than good here — with loss of appetite, dietary advice helps early, not only once kilos are already gone.

By the clock rather than as needed works better and needs less overall. Fear of dependence is the wrong adviser in this situation — untreated pain costs sleep, appetite and strength.

Psycho-oncological support, social advice for insurance and work, and the question of who takes on what at home. This is no emergency measure but belongs at the start — and the relatives belong in it.

Surgery aims to remove all visible tumour — no other point weighs as heavily on the further path, which is why it belongs in experienced hands. Platinum-based chemotherapy works well in most people; the question is how long the quiet lasts. PARP inhibitors as maintenance lengthen that quiet distinctly, especially with a BRCA change — they are taken over two to three years. CA 125 measures the course, not the diagnosis.

The signs are unspecific — bloating, early fullness, pressure in the belly and pelvis, passing urine often — but the time course is not: newly arisen, on more than twelve days a month, for less than a year. That pattern is exactly the most usable clue. A BRCA change raises the risk clearly; in about one in five cases a hereditary cause is found. There is no screening for the general population, because it did not lower mortality.

Bloating and a growing waistline over more than two to three weeks, almost daily — not the ups and downs many know from eating. That constancy is the decisive thing.

A few bites are enough although the hunger was there. Together with the growing belly that is the typical combination.

A lasting pressure or pain in the lower belly and a new, frequent or urgent need to pass water without signs of infection.

Almost every woman knows each of these on its own. They gain meaning when several are new, occur almost daily and last longer than three weeks. Then the ultrasound is the next step.

Together with an increasing waist and bloating over weeks, this is the combination that stands out here.

Not a screening test. It is also raised in endometriosis, with fibroids, during the period, in pregnancy and with inflammation in the abdomen — and it is often normal in early stages. It is mainly useful for following a course that is already known.

The loss of muscle mass helps decide how well a treatment is tolerated. Enough protein spread across the day, together with movement, is the part one holds oneself.

Low values are common with a longer illness, and correcting them counts for bone and muscle. For high-dose courses against the illness itself there are no studies; they can interfere with treatment.

Belong in the workup of an anaemia that is otherwise too quickly put down to the illness or the treatment. Both are easy to measure and easy to supplement.

Nausea, diarrhoea and fever dry one out quickly, and several treatments strain the kidney. Drinking enough is no side issue here.

If the ovaries are removed, oestrogen production ends abruptly instead of over years — bone loss starts correspondingly faster. Vitamin D, calcium and loading the bone are a topic here from the start, not only after the first abnormal finding.

Platinum-based chemotherapies can damage the nerves in hands and feet. B6 is often recommended against this — except that too much B6 damages nerves itself: from about 50 mg daily over months this is described. A complex at normal dosing is therefore safer than a single high dose.

With weight loss during therapy a slight stabilisation is described, in the order of about 2 g EPA daily. It is not an effect on the illness itself.

Clearly worthwhile and well supported when deficient — vegan, older adults, certain drugs. No energy boost without a deficiency.

Every pregnancy and every year on the pill lowers the risk measurably — the fewer ovulations, the rarer the disease. That is one of the few points where the numbers are unambiguous.

After the ovaries are removed before menopause, the menopause sets in at once and abruptly — not over years. The consequences for bone, vessels and sleep belong discussed before the operation.

In young women germ cell tumours of the ovary are a chapter of their own — they make markers such as hCG and AFP and are mostly well treatable. Preserving fertility belongs on the table there from the start.

Fluid in the belly can mask weight — muscle mass falls while the scale stays put. So protein and strength are watched, not only kilograms.

The claim usually rests on the PET scan: weakly radioactive glucose is injected, and the tumour lights up. That shows tumour cells take up sugar faster than the tissue next to them — not that eaten sugar feeds them. You come to a PET scan fasting, and the tumour lights up anyway; the body keeps blood sugar within narrow limits by itself. It cannot be starved out this way. There is an established link nonetheless, but it runs through body fat: in 2016 the International Agency for Research on Cancer (IARC) reviewed the available studies and found sufficient evidence, for thirteen cancers, that absence of excess weight lowers the risk. That concerns prevention — it is not an answer to where an existing illness came from.

Supervised training during treatment preserves muscle mass and improves fatigue. The intensity follows the day, not the plan.